Conclusion Although the global mortality rate and DALY rate for prostate cancer show a decreasing trend, the number of new cases, deaths, and DALYs continues to rise due to global population growth and the aging population, and the disease burden remains significant.
← all excerpts
Global burden of prostate cancer: age-period-cohort analysis from 1990 to 2021 and projections until 2040.
1
—
—